Skip to content

300759.SZ

Pharmaron Beijing Co., Ltd.

SZSE · Healthcare · M 科研服务 · CN

CNY 39.49
+6.01%
Ask drillr

Year over year

Reported trailing growth

Revenue
+14.7%
EBITDA
—
EBIT
-9.9%
EPS
-9.3%
Free cash flow
-52.2%
Operating cash flow
+10.8%

Forward estimates

Based on analyst estimates

Revenue
+25.4%
EBITDA
+69.3%
EPS
+73.4%

Three-year CAGR

Revenue
+11.1%
EBITDA
+9.4%
EBIT
+4.5%
Net income
+6.6%
EPS
+6.8%
Free cash flow
+3.0%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026